Nur 600 Exam 1 (St. Thomas University) – Questions
With Expert Solutions
Add to calendar
Play your way to mastery with fun games
Blocks Charms NEW Blast
Terms in this set (164)
Nurse practitioner prescriptive authority C. The State Board of Nursing for each state
is regulated by:
A. The National Council of State Boards
of Nursing
B. The U.S. Drug Enforcement
Administration
C. The State Board of Nursing for each
state
D. The State Board of Pharmacy
Physician Assistant (PA) prescriptive D. The State Board of Medical Examiners
authority is regulated by:
A. The National Council of State Boards
of Nursing
B. The U.S. Drug Enforcement
Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
,Clinical judgment in prescribing A. Factoring in the cost to the patient of the medication
includes: prescribed
A. Factoring in the cost to the patient of
the medication prescribed
B. Always prescribing the newest
medication available for the disease
process C. Handing out drug samples to
poor patients
D. Prescribing all generic medications to
cut costs
Criteria for choosing an effective drug B. Consulting nationally recognized guidelines for
for a disorder include: disease management
A. Asking the patient what drug they
think would work best for them
B. Consulting nationally recognized
guidelines for disease management
C. Prescribing medications that are
available as samples before writing a
prescription
D. Following U.S. Drug Enforcement
Administration (DEA) guidelines for
prescribing
,Nurse practitioner practice may thrive A. The demonstrated ability of nurse practitioners to
under health-care reform due to: control costs and improve patient outcomes
A. The demonstrated ability of nurse
practitioners to control costs and
improve patient outcomes
B. The fact that nurse practitioners will
be able to practice independently
C. The fact that nurse practitioners will
have full reimbursement under health-
care reform
D. The ability to shift accountability for
Medicaid to the state level
A patient's nutritional intake and lab A. Distribution of drugs to target tissue may be affected
work reflects hypoalbuminemia. This is
critical to prescribing because:
A. Distribution of drugs to target tissue
may be affected
B. The solubility of the drug will not
match the site of absorption
C. There will be less free drug available
to generate an effect
D. Drugs bound to albumin are readily
excreted by the kidney
Drugs that have a significant first-pass C. Are rapidly metabolized by the liver and may have
effect: A. Must be given by the enteral little if any desired action
(oral) route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver
and may have little if any desired action
D. Are converted by the liver to more
active and fat-soluble forms
The route of excretion of a volatile drug B. The lungs
will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin
, Medroxyprogesterone (Depo Provera) C. Increase the length of time a drug is available and
is prescribed IM to create a storage active
reservoir of the drug. Storage reservoirs:
A. Assure that the drug will reach its
intended target tissue
B. Are the reason for giving loading
doses
C. Increase the length of time a drug is
available and active
D. Are most common in collagen tissues
The NP chooses to give cephalexin B. Biological half-life
every 8 hours based on knowledge of
the drug's:
A. Propensity to go to the target
receptor
B. Biological half-life
C. Pharmacodynamics
D. Safety and side effects
Azithromycin dosing requires the first A. Rapidly achieves drug levels in the therapeutic range
day's dose be twice those of the other 4
days of the prescription. This is
considered a loading dose. A loading
dose: A. Rapidly achieves drug levels in
the therapeutic range
B. Requires four to five half-lives to
attain
C. Is influenced by renal function
D. Is directly related to the drug
circulating to the target tissues
The point in time on the drug C. Onset of action
concentration curve that indicates the
first sign of a therapeutic effect is the:
A. Minimum adverse effect level
B. Peak of action
C. Onset of action
D. Therapeutic range
With Expert Solutions
Add to calendar
Play your way to mastery with fun games
Blocks Charms NEW Blast
Terms in this set (164)
Nurse practitioner prescriptive authority C. The State Board of Nursing for each state
is regulated by:
A. The National Council of State Boards
of Nursing
B. The U.S. Drug Enforcement
Administration
C. The State Board of Nursing for each
state
D. The State Board of Pharmacy
Physician Assistant (PA) prescriptive D. The State Board of Medical Examiners
authority is regulated by:
A. The National Council of State Boards
of Nursing
B. The U.S. Drug Enforcement
Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
,Clinical judgment in prescribing A. Factoring in the cost to the patient of the medication
includes: prescribed
A. Factoring in the cost to the patient of
the medication prescribed
B. Always prescribing the newest
medication available for the disease
process C. Handing out drug samples to
poor patients
D. Prescribing all generic medications to
cut costs
Criteria for choosing an effective drug B. Consulting nationally recognized guidelines for
for a disorder include: disease management
A. Asking the patient what drug they
think would work best for them
B. Consulting nationally recognized
guidelines for disease management
C. Prescribing medications that are
available as samples before writing a
prescription
D. Following U.S. Drug Enforcement
Administration (DEA) guidelines for
prescribing
,Nurse practitioner practice may thrive A. The demonstrated ability of nurse practitioners to
under health-care reform due to: control costs and improve patient outcomes
A. The demonstrated ability of nurse
practitioners to control costs and
improve patient outcomes
B. The fact that nurse practitioners will
be able to practice independently
C. The fact that nurse practitioners will
have full reimbursement under health-
care reform
D. The ability to shift accountability for
Medicaid to the state level
A patient's nutritional intake and lab A. Distribution of drugs to target tissue may be affected
work reflects hypoalbuminemia. This is
critical to prescribing because:
A. Distribution of drugs to target tissue
may be affected
B. The solubility of the drug will not
match the site of absorption
C. There will be less free drug available
to generate an effect
D. Drugs bound to albumin are readily
excreted by the kidney
Drugs that have a significant first-pass C. Are rapidly metabolized by the liver and may have
effect: A. Must be given by the enteral little if any desired action
(oral) route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver
and may have little if any desired action
D. Are converted by the liver to more
active and fat-soluble forms
The route of excretion of a volatile drug B. The lungs
will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin
, Medroxyprogesterone (Depo Provera) C. Increase the length of time a drug is available and
is prescribed IM to create a storage active
reservoir of the drug. Storage reservoirs:
A. Assure that the drug will reach its
intended target tissue
B. Are the reason for giving loading
doses
C. Increase the length of time a drug is
available and active
D. Are most common in collagen tissues
The NP chooses to give cephalexin B. Biological half-life
every 8 hours based on knowledge of
the drug's:
A. Propensity to go to the target
receptor
B. Biological half-life
C. Pharmacodynamics
D. Safety and side effects
Azithromycin dosing requires the first A. Rapidly achieves drug levels in the therapeutic range
day's dose be twice those of the other 4
days of the prescription. This is
considered a loading dose. A loading
dose: A. Rapidly achieves drug levels in
the therapeutic range
B. Requires four to five half-lives to
attain
C. Is influenced by renal function
D. Is directly related to the drug
circulating to the target tissues
The point in time on the drug C. Onset of action
concentration curve that indicates the
first sign of a therapeutic effect is the:
A. Minimum adverse effect level
B. Peak of action
C. Onset of action
D. Therapeutic range
